Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)

NCT02773225 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Anemia, Aplastic

Interventions

DRUG: Eltrombopag
DRUG: Placebo (for Eltrombopag)

Sponsor

B. Höchsmann